Kimberley Ann Kolb is a pharmacist who is specialized in Oncology in Louisville, Kentucky. Patients can reach her at 4003 Kresge Way Ste 500, Louisville or contact her on 502-721-6044. Active license number of Kimberley Ann Kolb is 010724 for Oncology in Kentucky. Kimberley Ann Kolb is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Kimberley Ann Kolb speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kimberley Ann Kolb
Specialization:
Oncology
Gender:
Female
Location:
4003 Kresge Way Ste 500, Louisville, Kentucky, 40207-5603
Phone:
502-721-6044
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kimberley Ann Kolb are as mentioned below.
NPI Number:
1821876251
NPI Enumeration Date:
18 Sep, 2023
NPI Last Update On:
18 Sep, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kimberley Ann Kolb are as mentioned below.
Specialization
License Number
State
Status
Oncology
010724
Kentucky
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5613 Morrison Ave, Louisville, Kentucky
Zip:
40214-1201
Phone Number:
502-216-9604
Fax Number:
502-928-2790
Patients can reach Kimberley Ann Kolb at 4003 Kresge Way Ste 500, Louisville, Kentucky or can call on phone at 502-721-6044.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.